SEC Form 4 · accession 0001209191-15-085109

LEMAITRE VASCULAR INC · LMAT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chief Financial Officer

Period of report

Dec 10, 2015

Accepted (ET)

Dec 14, 2015 · 5:55 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001158895

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock^F1	Dec 10, 2015	M	18,611	$7.10	A	129,000	D
Common Stock^F2	Dec 10, 2015	S	18,611	$16.0078	D	110,389	D
Common Stock^F1	Dec 10, 2015	M	2,422	$6.23	A	112,811	D
Common Stock^F2	Dec 10, 2015	S	2,422	$16.0078	D	110,389	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (Right to Buy)^F3	$7.10	Dec 10, 2015	M	18,611	D	Jul 26, 2011	Jul 26, 2018	Common Stock	18,611	8,240	D
Stock Option (Right to Buy)^F3	$6.23	Dec 10, 2015	M	2,422	D	Jul 25, 2012	Jul 25, 2019	Common Stock	2,422	46,561	D

F1Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II.
F2The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $16.00 to $16.03. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
F3This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining four years.